Navigation Links
Xanodyne Pharmaceuticals Appoints New Chief Operating Officer

NEWPORT, Ky. and MOUNT ARLINGTON, N.J., May 17, 2011 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc., is pleased to announce that Fabrice Egros has been appointed to the position of Chief Operating Officer reporting to Natasha Giordano, President and Chief Executive Officer.

Fabrice Egros has more than 20 years of experience in the pharmaceutical industry and prior to Xanodyne served in various senior positions in UCB Pharmaceuticals (Belgium, US and Japan).  His depth of experience includes senior leadership positions in general management, corporate business development, clinical development & regulatory as well as marketing and sales in Europe, Asia and the US at major pharmaceutical companies including Sanofi-Aventis and Parke-Davis.

Mr. Egros said, "I look forward to working with Natasha and the management team in continuing to drive toward our vision of being a leader in the pain management category.  Xanodyne has a proven track record of bringing innovative products to the market and developing strategic partnerships where desired, as well as the people, resources and strategy to focus Xanodyne on high growth opportunities within the pain franchise."  

Ms. Giordano said, "I am very pleased to welcome Fabrice to our management team.  His global knowledge of the industry, deep experience in corporate development and his strong leadership will help us achieve our strategic goals and commercial success in pain management."

About Xanodyne Pharmaceuticals, Inc.

Xanodyne Pharmaceuticals, Inc., founded in 2001, is an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management. Xanodyne markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins.  Additionally, we are advancing a late stage pipeline of product candidates targeted at significant potential markets in Xanodyne's focus area.  For more information, visit

SOURCE Xanodyne Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Xanodyne Agrees to Withdraw Propoxyphene From the U.S. Market
2. Xanodyne Announces Planned President & CEO Succession
3. Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
4. Xanodyne Announces Renewed Focus on Pain Management Market
5. Xanodyne Expands U.S. Sales Force and Launches Zipsor(TM) (diclofenac potassium) Liquid Filled Capsules
6. Xanodyne Raises $50 Million in Equity Financing to Support Emerging Product Portfolio
7. Access Pharmaceuticals Provides Update on MuGard Commercial Activities
8. Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011
9. Amylin Pharmaceuticals Files Suit Against Eli Lilly
10. Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
11. Reportlinker Adds Pharmaceuticals Reports Bundle
Post Your Comments:
(Date:11/30/2015)... 2015   Nuance Communications, Inc. (NASDAQ: ... Company (NDSC) today jointly announced a new integrated ... utilize the American College of Radiology,s (ACR) Imaging 3.0™ ... comply with current and emerging value-based payment models ... By combining clinical decision support, radiology reporting and ...
(Date:11/30/2015)... N.J. , Nov. 30, 2015  Novartis will ... at the 57 th American Society of Hematology ... lymphomas and myelomas as well as supportive care, including ... addition to personalized cell therapies. The ASH Annual Meeting ... Florida . Novartis Oncology . "We ...
(Date:11/30/2015)... REHOVOT, Israel , Nov. 30, 2015 ... focused on acquiring and developing innovative therapies for ear, ... of Keith A. Katkin as chairman of ... Flesher , chief executive officer for OticPharma, Ltd.  "Keith ... As chairman, he will be able to share this ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... ... as their exclusive channel partner for the Nutraceutical Specialties products into oral solid ... US, effective immediately. , “We are pleased to announce our expanded distribution ...
(Date:11/30/2015)... ... November 30, 2015 , ... While powdered supplements and drinks can reduce food ... inventor from Chesterfield, Va., has found an easy to keep track of the scoop. ... measure powdered contents in a canister or other container handy and readily accessible. As ...
(Date:11/30/2015)... ... ... In an interview with Andy Mitchell of Peconic Bay Medical Center, Dr. ... end. During the broadcast, entitled “Eyes: the Window to the Soul,” Dr. Buono discusses ... how a visit with his grandmother to her physician put him on a rewarding ...
(Date:11/30/2015)... ... November 30, 2015 , ... It’s inevitable that everyone will experience death in ... animal pass away, death lives among us. It is your perspective, however, that determines ... of 11 children, author T Sky understands that she may see death more frequently ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
Breaking Medicine News(10 mins):